CHCI Comstock Holding Companies (CHCI) Insider Trading, Ownership & Congress Trades
Real Estate · Real estate · CIK 0001299969
SEC filings
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $66.0K priced
What the filings say about CHCI
Insiders, 180 days
-$174.2K net sold
1 buyer · 1 seller · 0% of sales under a 10b5-1 plan
Comstock Holding Companies insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Comstock Holding Companies, Inc. insiders sold a net $174.2K of stock across 28 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 100.0% of the 600 shares held after it.
- No other insider bought within 30 days.
Insider activity: Director Hirsh David Z. bought about $11.2K of CHCI on Aug 18, 2026, the largest insider purchase at the company on our record.Context
- 12 earlier Form 4 trades (code P or S) here by this insider (12 sales), the last on Mar 23, 2026.
- The trade is 10.6% of the 122,741 shares held after it.
- No other insider sold within 30 days.
Insider activity: Chief Operating Officer Steffan Timothy sold about $185.4K of CHCI on May 21, 2026, the largest insider sale at the company on our record.Context
- 11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Aug 20, 2025.
- The trade is 8.4% of the 115,767 shares held after it.
- No other insider sold within 30 days.
Insider activity: Chief Operating Officer Steffan Timothy sold about $152.0K of CHCI on Mar 23, 2026, the largest insider sale at the company on our record.Context
- 10 earlier Form 4 trades (code P or S) here by this insider (10 sales), the last on Aug 19, 2025.
- The trade is 1.2% of the 91,510 shares held after it.
- 2 other insiders sold within 30 days.
Insider activity: Chief Operating Officer Steffan Timothy sold about $16.4K of CHCI on Aug 20, 2025; 2 other insiders sold within 30 days.Context
- 9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Aug 15, 2025.
- The trade is 3.7% of the 92,564 shares held after it.
- 2 other insiders sold within 30 days.
Insider activity: Chief Operating Officer Steffan Timothy sold about $53.7K of CHCI on Aug 19, 2025; 2 other insiders sold within 30 days.28 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$174.2K over 180 days
+$11.2K over 90 days
below 59% of Real Estate
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+22.6% year over year
more than 84% of Real Estate
Margin
27.1% net margin
more than 67% of Real Estate
Buybacks
no share repurchases reported
Short interest
3.1% of the float short (float per yahoo 2026-10-26) · 2.5 days to cover · settled 2026-09-30
below 79% of Real Estate
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CHCI
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+23.6%12M
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CHCI: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in CHCI
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CHCI planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$2.3M
$2.3M
$1.7M
+173%
n/a
2024
$1.6M
$1.6M
$972.7K
+90%
n/a
2023
$1.4M
$1.4M
$906.2K
+4%
n/a
2022
$1.1M
$1.1M
$1.1M
-12%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $174.2K sold by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
CHCI financials
Revenue growth
+22.6%
XBRL, annual
Net margin
27.1%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$77.3M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CHCI
| FY Dec 2025 | $62.9M |
| FY Dec 2024 | $51.3M |
| FY Dec 2023 | $44.7M |
| FY Dec 2022 | $39.3M |
| FY Dec 2021 | n/a |
| Jun 2026 | $22.6M |
| Mar 2026 | $17.4M |
| Dec 2025 | $23.9M |
| Sep 2025 | $13.3M |
| Jun 2025 | $13.0M |
| Mar 2025 | $12.6M |
| Dec 2024 | $16.9M |
| Sep 2024 | $13.0M |
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM CHCI
| FY Dec 2025 | n/a |
| FY Dec 2024 | +11.9% |
| FY Dec 2023 | +17.4% |
| FY Dec 2022 | +18.7% |
| FY Dec 2021 | n/a |
| Jun 2026 | +39.2% |
| Mar 2026 | +11.4% |
| Dec 2025 | n/a |
| Sep 2025 | +4.1% |
| Jun 2025 | +11.1% |
| Mar 2025 | +12.6% |
| Dec 2024 | n/a |
| Sep 2024 | +18.3% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$10.3M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CHCI
| FY Dec 2025 | $4.7M |
| FY Dec 2024 | $10.5M |
| FY Dec 2023 | $8.9M |
| FY Dec 2022 | $3.4M |
| FY Dec 2021 | $3.4M |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
0.07x
long-term 2021-12-31 (54 months older than the period end) plus current 2020-12-31 (66 months older than the period end); equity 2026-06-30
Debt to equity CHCI
| FY Dec 2025 | 0.08x |
| FY Dec 2024 | 0.13x |
| FY Dec 2023 | 0.15x |
| FY Dec 2022 | 0.19x |
| FY Dec 2021 | 0.22x |
| Jun 2026 | 0.07x |
| Mar 2026 | 0.08x |
| Dec 2025 | 0.08x |
| Sep 2025 | 0.10x |
| Jun 2025 | 0.10x |
| Mar 2025 | 0.10x |
| Dec 2024 | 0.13x |
| Sep 2024 | 0.13x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.89x
TTM operating cash flow over long-term 2021-12-31 (54 months older than the period end) plus current 2020-12-31 (66 months older than the period end)
Cash flow to debt CHCI
| FY Dec 2025 | 0.87x |
| FY Dec 2024 | 1.94x |
| FY Dec 2023 | 1.64x |
| FY Dec 2022 | 0.65x |
| FY Dec 2021 | 0.65x |
| Jun 2026 | 1.89x |
| Mar 2026 | -0.28x |
| Dec 2025 | 0.87x |
| Sep 2025 | 1.33x |
| Jun 2025 | 2.62x |
| Mar 2025 | 2.44x |
| Dec 2024 | 1.94x |
| Sep 2024 | 2.23x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on equity CHCI
| FY Dec 2025 | n/a |
| FY Dec 2024 | +15.9% |
| FY Dec 2023 | +23.6% |
| FY Dec 2022 | +27.1% |
| FY Dec 2021 | +74.5% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | +15.9% |
| Sep 2024 | +15.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on assets CHCI
| FY Dec 2025 | n/a |
| FY Dec 2024 | +12.3% |
| FY Dec 2023 | +16.8% |
| FY Dec 2022 | +17.1% |
| FY Dec 2021 | +37.7% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | +12.3% |
| Sep 2024 | +12.3% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate -12%, not meaningful
Return on invested capital CHCI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | +37.6% |
| FY Dec 2022 | +41.6% |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | +22.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+22.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed CHCI
| FY Dec 2025 | +17.9% |
| FY Dec 2024 | +23.0% |
| FY Dec 2023 | +23.0% |
| FY Dec 2022 | +21.6% |
| FY Dec 2021 | +16.4% |
| Jun 2026 | +22.5% |
| Mar 2026 | +17.2% |
| Dec 2025 | +17.9% |
| Sep 2025 | +16.9% |
| Jun 2025 | +21.5% |
| Mar 2025 | +20.9% |
| Dec 2024 | +23.0% |
| Sep 2024 | +16.0% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
22.82x
close 2026-10-26 over four quarters of diluted EPS, 2023-04-01 to 2024-03-31
P/E, trailing CHCI
| FY Dec 2025 | 14.90x |
| FY Dec 2024 | 10.36x |
| FY Dec 2023 | 5.83x |
| FY Dec 2022 | 4.38x |
| FY Dec 2021 | 3.23x |
| Jun 2026 | 20.50x |
| Mar 2026 | 24.28x |
| Dec 2025 | 14.90x |
| Sep 2025 | 17.96x |
| Jun 2025 | 12.94x |
| Mar 2025 | 11.05x |
| Dec 2024 | 10.36x |
| Sep 2024 | 12.81x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$127.8M
market value at close 2026-10-26 on 2021-03-26 shares, plus long-term 2021-12-31 (54 months older than the period end) plus current 2020-12-31 (66 months older than the period end), minus cash 2026-06-30
Enterprise value CHCI
| FY Dec 2025 | $70.6M |
| FY Dec 2024 | $43.8M |
| FY Dec 2023 | $23.5M |
| FY Dec 2022 | $29.0M |
| FY Dec 2021 | $29.9M |
| Jun 2026 | $112.8M |
| Mar 2026 | $143.0M |
| Dec 2025 | $70.6M |
| Sep 2025 | $95.6M |
| Jun 2025 | $58.7M |
| Mar 2025 | $48.7M |
| Dec 2024 | $43.8M |
| Sep 2024 | $67.3M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.9%
TTM free cash flow over market value at close 2026-10-26
FCF yield CHCI
| FY Dec 2025 | +4.8% |
| FY Dec 2024 | +15.7% |
| FY Dec 2023 | +24.1% |
| FY Dec 2022 | +9.7% |
| FY Dec 2021 | +8.5% |
| Jun 2026 | +7.7% |
| Mar 2026 | -1.1% |
| Dec 2025 | +4.8% |
| Sep 2025 | +6.2% |
| Jun 2025 | +17.1% |
| Mar 2025 | +18.6% |
| Dec 2024 | +15.7% |
| Sep 2024 | +14.6% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -8%, PEG needs growth
PEG, trailing CHCI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $62.9M | $51.3M | $44.7M | $39.3M |
| Operating income | $11.9M | $10.3M | $9.2M | $8.0M |
| Net income | $17.1M | $14.6M | $7.8M | $7.3M |
| EPS (diluted) | n/a | n/a | 0.77 | 0.98 |
| Operating cash flow | $4.8M | $10.7M | $9.0M | n/a |
| Cash | $31.3M | $28.8M | $18.8M | $11.7M |
SEC XBRL, fiscal years, as known on 2026-10-28
CHCI Stock Sonar score 4/7 axes
Find similar shapesCompareCHCI ranks highest on financial health (93rd percentile) and growth (84th), and lowest on insider conviction (46th), among Real Estate peers.
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CHCI filings, in plain words
Are Comstock Holding Companies insiders buying or selling CHCI?
In the 180 days to 2026-10-28, Comstock Holding Companies insiders were net sellers, a net $174.2K: $11.2K of purchases and $185.4K of sales reported on Form 4, by 1 buyer and 1 seller.
Read the full summary
In the 180 days to 2026-10-28, Comstock Holding Companies insiders were net sellers of CHCI, a net $174.2K across purchases and sales reported on Form 4 by 1 buyer and 1 seller. Sales outweighed purchases more than tenfold by value. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
